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M A J O R A R T I C L E
Suppression of Basophil Histamine Release and
Other IgE-dependent Responses in Childhood
Schistosoma mansoni/hookworm Coinfection
Angela Pinot de Moira,1 Colin M. Fitzsimmons,1 Frances M. Jones,1 Shona Wilson,1 Pierre Cahen,1 Edridah Tukahebwa,2
Harriet Mpairwe,3 Joseph K. Mwatha,4 Jeffrey M. Bethony,5 Per S. Skov,6 Narcis B. Kabatereine,2 and David W. Dunne1
1Department of Pathology, University of Cambridge, Cambridge, United Kingdom; 2Vector Control Division, Ministry of Health, Kampala, Uganda; 3MRC/
UVRI Uganda Research Unit on AIDS, Entebbe, Uganda; 4Centre for Biotechnology Research and Development, Kenya Medical Research Institute, Nairobi,
Kenya; 5Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington, DC; and 6RefLab ApS,
Copenhagen, Denmark
Background. The poor correlation between allergen-specific immunoglobulin E (asIgE) and clinical signs of al-
lergy in helminth infected populations suggests that helminth infections could protect against allergy by uncoupling
asIgE from its effector mechanisms. We investigated this hypothesis in Ugandan schoolchildren coinfected with
Schistosoma mansoni and hookworm.
Methods. Skin prick test (SPT) sensitivity to house dust mite allergen (HDM) and current wheeze were assessed
pre-anthelmintic treatment. Nonspecific (anti-IgE), helminth-specific, and HDM-allergen-specific basophil histamine
release (HR), plus helminth- and HDM-specific IgE and IgG4 responses were measured pre- and post-treatment.
Results. Nonspecific- and helminth-specific-HR, and associations between helminth-specific IgE and helminth-
specific HR increased post-treatment. Hookworm infection appeared to modify the relationship between circulating
levels of HDM-IgE and HR: a significant positive association was observed among children without detectable hook-
worm infection, but no association was observed among infected children. In addition, hookworm infection was as-
sociated with a significantly reduced risk of wheeze, and IgG4 to somatic adult hookworm antigen with a reduced risk
of HDM-SPT sensitivity. There was no evidence for S. mansoni infection having a similar suppressive effect on HDM-
HR or symptoms of allergy.
Conclusions. Basophil responsiveness appears suppressed during chronic helminth infection; at least in hook-
worm infection, this suppression may protect against allergy.
Keywords. Schistosoma mansoni; schistosomiasis; hookworm; helminth infection; allergy; skin prick test;
wheeze; basophils; histamine release; house dust mite.
Prevalence of allergy has increased markedly since the
beginning of the 20th century [1].Epidemiological obser-
vations suggest that this may be related to environmental
and lifestyle changes associated with urbanization, as al-
lergies appear more common in developed than in
developing countries [2], and even within countries
there appears to be distinct division between rural and
urban environments [3–5]. Furthermore, as urbanization
increases in developing countries, the burden of allergy
appears also to be increasing [6].
Allergic (immunoglobulin E [IgE]-mediated) disor-
ders are usually confirmed by measuring skin prick
test (SPT) sensitivity or allergen-specific IgE (asIgE)
[7]. However, these 2 measures are often poorly corre-
lated and weakly specific for clinical phenotypes. In a
large-scale study conducted by the International Study
of Asthma and Allergy in Childhood (ISAAC) group,
this discordance varied dramatically by geography,
with a strong negative correlation with gross national
income per capita (GNI) [8]. Furthermore, although
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no overall association between asIgE and GNI was observed,
there was a weak positive association between SPT and GNI.
Similar observations have been made elsewhere [9]. One expla-
nation could be the greater prevalence of helminth infection in
lower GNI countries. Infection with helminths has similarly
been associated with discordance between asIgE and SPT sensi-
tivity [10–12], and there is growing evidence that at least some
species of helminth protect against allergy [13, 14].
Immune responses seen in allergy and during helminth infec-
tion are markedly similar. Both are Th2-biased, with elevated
levels of interleukin 4, interleukin 5, and interleukin 13 cyto-
kines, IgE and IgE-effector cells, such as basophils and eosino-
phils. In helminthiasis, specific IgE responses are associated
with immunity to infection [15–18]; however, this immunity
is only partial and appears finely balanced between the IgE-
effector mechanisms of IgE and IgG4 down-regulatory effects
[16, 18–21], which is able to block IgE antigen binding and sup-
press IgE-effector cells by engaging FcγRIIB [22]. Regulatory
cells and cytokines such as Tregs, interleukin 10, and trans-
forming growth factor β are also up-regulated in helminthiasis
[23], together preventing allergic inflammation.
We hypothesize that immunoregulatory responses seen in
helminth infection reduce the response of IgE-effector cells
such as basophils to IgE-mediated activation, uncoupling IgE
from its effector mechanisms, resulting in suppressed responses
to both parasite and nonparasite antigens. Here, we test this hy-
pothesis in schoolchildren from an area co-endemic for Schisto-
soma mansoni and hookworm by (1) measuring changes in
specific and nonspecific histamine release (HR) in whole
blood 8 weeks after concurrent praziquantel and albendazole
administration to treat schistosomiasis and hookworm, respec-
tively, and (2) examining associations between antigen-specific-
IgE and antigen-specific-HR, and how these are influenced by
helminth infection. We further hypothesize that the uncoupling
of asIgE from its effector mechanisms has downstream effects to
limit allergy; we test this by measuring house dust mite skin-
prick-test (HDM-SPT) sensitivity and current wheeze, and
how these are influenced by current helminth infection.
MATERIALS AND METHODS
Study Population
This study was conducted in Bwondha Village, on the shoreline
of Lake Victoria, Mayuge District, Uganda. Ethical clearance
was obtained from the Uganda National Council of Science
and Technology. Full study details are given elsewhere [24].
Briefly, a register of all children (n = 795) attending Bwondha
Primary School was drawn up and from this, 350 children
aged 7–16 years were selected by simple random sampling.
Written informed consent was obtained from all parents/guard-
ians of sampled individuals who agreed to participate. Ques-
tionnaires were administered to the most relevant parent/
guardian, recording household socioeconomic characteristics
(eg, parental occupation and education, house construction,
water sources, sanitation, asset ownership). Wheeze in the last
12 months was collected by questions adapted from the ISAAC
questionnaire [2]; recall bias is likely to minimal within 12
months. All questionnaires were translated and administered
in Luganda, the predominant language in Bwondha.
Treatment, Blood and Stool Collection
In July 2010, 350 children were treated once with albendazole
(400 mg) and twice with praziquantel (40 mg/kg bodyweight,
1 week apart). Venous blood samples (5 mL) were collected
from children pretreatment and 8 weeks post-treatment.
Three stool samples were collected on 3 consecutive days, pre-
treatment and 5 weeks post-treatment, to detect treatment fail-
ure/noncompliance and determine treatment efficacy. Two
50 mg Kato-Katz thick-smear slides were prepared from each
sample and examined microscopically (within 30 minutes of
preparation for hookworm quantification). Of the 350 children
recruited, 240 completed the study. Loss to follow-up was main-
ly related to the transient nature of the study population.
Parasite and Environmental Antigens
Crude somatic adult hookworm antigen extract (AHW) was
prepared from Ancylostoma caninum, from canines. A Puerto
Rican strain of S. mansoni, maintained in outbred mice and Bi-
omphalaria glabrata, was used for production of schistosome
crude antigens. Adult worms were recovered from mice 6
weeks after infection, and parasite eggs isolated from liver tis-
sue. Soluble worm antigen (SWA) was prepared from frozen
worms, and saline-soluble egg antigen (SEA) from frozen
eggs, as described elsewhere [15, 25]. House dust mite antigen
(HDM) was an equal mixture of Dermatophagoides farinae and
D. pteronyssinus; Greer, Lenoir, USA).
Skin Prick Testing
Skin prick testing for HDM sensitivity was conducted pretreat-
ment using standard procedures [26]. Histamine was used as a
positive control and saline solution as a negative control. A
mean wheal diameter ≥3 mm compared to the negative control
was defined as a positive reaction, with the reading taken 15
minutes after pricking allergen onto the volar side of the fore-
arm. HDM allergen, controls, and lancets were obtained from
ALK-Abello (Horsholm, Denmark).
Histamine Release Assays
Histamine-binding glass fiber-coated microtitre plates (RefLab
ApS, Copenhagen, Denmark) were coated with 25 µL/well of
antigen in triplicate, at concentrations of 7 µg/mL (α-IgE,
Dako, Glostrop, Denmark), 20 µg/mL (SEA), 20 µg/mL (SWA),
and 7 µg/mL (HDM), and with histamine standards, in triplicate,
at 80, 50, 40, 30, and 10 µg/mL, diluted in water containing 5%
glycerol. Coated plates were dried for 6 hours at 37°C, then
packed and sealed for use in Bwondha. 25 µL/well of AHW
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antigen at 20 µg/mL diluted in PIPES Buffer (RefLab ApS) were
added in triplicate to plates in the field.
HR assays followed a similar protocol to that described pre-
viously [27] but with the washing stage omitted, thus measuring
direct HR by unwashed whole blood. Briefly, 25 µL of PIPES
buffer was added to each well of glass fiber-coated microtitre an-
tigen-coated plates to dissolve antigen, followed by 25 µL of un-
washed whole blood. Plates were incubated for 1 hour at 37°C to
allow HR and then washed with distilled H2O. Plates were dried,
away from direct sunlight for 24 hours, and then stored in the
dark at room temperature before being shipped to Cambridge,
United Kingdom, for histamine analysis. Histamine was mea-
sured by spectrofluorometry as described elsewhere [28], and
results were expressed as ng HR/mL blood.
Antibody Assays
Plasma was separated from venous blood samples and stored at
−80°C until required. IgE and IgG4 levels to AHW, SEA, SWA,
and HDM were measured by enzyme-linked immunosorbent
assay (ELISA) as described elsewhere [29]. Briefly, antigen,
15 µL/well, was placed in 384-well plates at saturation coating
concentrations of 5 µg/mL (AHW), 1.2 µg/mL (SEA), 8 µg/mL
(SWA), and 2 µg/mL (HDM) as determined by titration. 15 µL
of sample plasma and noninfected plasma controls were assayed
in duplicate at dilutions of 1/20 (IgE) and 1/200 (IgG4). A 3-
fold serial dilution of purified human IgG4 (Sigma-Aldrich)
or IgE myeloma (Calbiochem) was added directly to each
plate to form a 14-point standard curve, starting at 30 µg/mL.
For schistosome and HDM assays, detection was as described
in Fitzsimmons et al [29]. For AHWassays, detection was as de-
scribed in Pinot de Moira et al [24].
For total-IgE (tIgE) ELISAs, microplates were coated in
carbonate/bicarbonate coating buffer pH9.6 with 15 µL/well
of mouse monoclonal anti-human IgE antibody, clone G7-18
at 2 µg/mL (BD Pharmingen, Oxford, UK) and monoclonal
mouse anti-human biotinylated IgE (clone G7-26) (BD Phar-
mingen) was used for detection. Otherwise assays were as de-
scribed above.
Statistical Analysis
Infection intensity was expressed as mean egg count per gram
(epg). Due to overdispersion, epg values were transformed to
the logarithm, ln(epg + 1) for statistical analysis. Details relating
to household economic characteristics were used to construct a
proxy measure of socioeconomic status (SES), using principle
component analysis, as described elsewhere [30, 31].
Detection thresholds for positive helminth-specific isotype
responses were calculated as the mean plus 3 standard devia-
tions (SD) of noninfected European control plasma samples,
and for tIgE and anti-HDM responses, as the mean plus 3
SDs of blank wells. Histamine readings were analyzed after sub-
tracting spontaneous HR. Due to overdispersion, antibody and
histamine readings were log-transformed with an integer giving
the best transformation, k, added/subtracted, and geometric
means (GM) calculated.
Significant changes between HR pre- and post-treatment
were determined using paired t-tests. Associations between an-
tigen-specific HR and antigen-specific IgE were explored using
linear regression analysis; the significance of any change in
these associations post-treatment was tested using 2-level linear
regression models to allow for correlation within children, with
time as “level 1” units and child as “level 2” units, with an in-
teraction term fitted between time and antigen-specific IgE.
Two further analyses were conducted on HDM-HR data:
(i) the effect modifying behavior of hookworm infection or
S. mansoni infection intensity on associations between HDM-
IgE and HDM-HR were analyzed using pretreatment data in
linear regression analysis, with an interaction term between
HDM-IgE and hookworm prevalence or ln(S. mansoni epg + 1);
(ii) change between HDM-HR pre- and post-treatment was cal-
culated as the difference between logarithms of post- and pre-
treatment HR; linear regression models were then constructed
to analyze how post-treatment HDM-IgE and pretreatment in-
fection influenced this change, with an interaction term be-
tween HDM-IgE and hookworm prevalence or ln(S. mansoni
epg + 1). For both of these analyses hookworm was included as a
binary variable for ease of interpretation and to ensure correct
specification of the model; the high prevalence of schistosomia-
sis gave insufficient power to model S. mansoni as a binary var-
iable, therefore, it was included as a continuous variable.
Pretreatment helminth infection and antibody response ef-
fects on HDM-SPT sensitivity and current wheeze was analyzed
using logistic regression. All regression models were adjusted
for age, sex, and SES; for this, age was classified into 2 binary
groups of roughly equal size (7–10 years, 11–16 years) and
SES fitted as the logarithm of the continuous variable.
Multilevel models were fitted in MLwiN (Bristol University,
UK); all other analyses were conducted using Stata 12.1 (Stata-
Corp, USA).
RESULTS
Study Characteristics
As detailed elsewhere [24], of the 350 children selected for re-
cruitment, 240 were enrolled in the study and provided assent,
donated at least 2 pretreatment stool samples, blood samples
pre- and 8-weeks post-treatment, and complied with treatment
procedures. The comparative characteristics of these 240 chil-
dren and original 350 children selected are given in Table 1.
S. mansoni and hookworm infection prevalence was 93.8%
(95% confidence interval [CI], 89.9%, 96.5%) and 80.4% (95%
CI, 74.8%, 85.2%), respectively; overall GM infection intensity
was 172.73 (95% CI, 131.61, 226.72) for S. mansoni and 71.75
(95% CI, 51.52, 99.90) for hookworm.
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Changes in Nonspecific (α-IgE-induced) HR 8 Weeks Post-
Anthelmintic Treatment
Total IgE levels decreased significantly post-treatment (Figure 1,
P = .04). Figure 2 shows pre- and post-treatment in vitro
basophil HR following incubation of whole blood with specific
antigen or α-IgE; P-values indicate the level of significance for
pre- vs post-treatment differences. Despite a decrease in tIgE,
α-IgE-HR increased significantly post-treatment (Figure 2).
Changes in Hookworm-HR 8 Weeks Post-Anthelmintic
Treatment
Although AHW-IgG4 decreased significantly post-treatment
(P < .001), AHW-IgE responses were not affected by treatment
(P = .97, Figure 1). Despite no increase in AHW-IgE, AHW-HR
increased dramatically post-treatment, from a GM of 6.50 ng/
mL (95% CI, 5.77, 7.33) to a GM of 16.57 ng/mL (95% CI,
14.94, 18.36; Figure 2).
Table 1. Pretreatment Characteristics of Participating Children
N (%)
Original Sample (n = 350) Participantsa (n = 240)
Age, years
7–8 104 (29.7) 61 (25.4)
9–10 80 (22.9) 57 (23.8)
11–12 106 (30.3) 82 (34.2)
13–16 60 (17.1) 40 (16.7)
Sex
Male 169 (48.3) 117 (48.8)
Female 181 (51.7) 123 (51.3)
SES
Lower 140 (40.0) 96 (40.0)
Middle 140 (40.0) 95 (39.6)
Upper 70 (20.0) 49 (20.4)
Wheeze
No wheeze 277 (92.6) 201 (91.8)
Wheeze 22 (7.36) 18 (8.2)
HDM SPT
Negative 295 (96.4) 227 (95.8)
Positive 11 (3.6) 10 (4.2)
Total IgE (IU/mL) [GMb, (95% CI)] 83.58 (73.93, 94.50) 85.09 (74.74, 96.87)
HDM-IgE (IU/mL) [GMb, (95% CI)] 0.136 (.125, .147) 0.138 (.126, .151)
HDM-IgE responsiveness
Negativec 203 (74.1) 170 (73.0)
Positivec 71 (25.9) 63 (27.0)
HDM-IgG4 responsiveness
Negativec 258 (94.2) 220 (94.4)
Positivec 16 (5.8) 13 (5.6)
S. mansoni infection prevalence 319 (91.1) 225 (93.8)
S. mansoni infection intensity [GM epg + 1, (95% CI)] 147.42 (116.82, 186.02) 172.73 (131.61, 226.72)
Hookworm infection prevalence 271 (77.4) 193 (80.4)
Hookworm infection intensity [GM epg + 1, (95 CI)] 67.16 (50.49, 89.34) 71.75 (51.52, 99.90)
Other helminth infection 125 (35.7) 89 (37.1)d
Abbreviations: CI, confidence interval; epg,egg count per gram; GM, geometric mean; HDM,house dust mite allergen; IgE, immunoglobulin E; SES, socioeconomic
status.
a Children completing the study, ie, children who provided assent, donated at least 2 pretreatment stool samples, blood samples pretreatment and 8 weeks post-
treatment, and complied with treatment procedures (n = 240).
b An integer, k, was added to antibody readings before calculating geometric means; k = 1.33445 (t-IgE), k= 0.095 (DM-IgE).
c Detection threshold calculated as the mean + 3 SD of blank wells = 0.228 (HDM-IgE), 1.22 (HDM-IgG4).
d Specific prevalence of other helminth infections: Trichuris trichiura = 28.3%; Hymenolepis nana = 10.8%; Enterobius vermicularis = 5.4%; Ascaris
lumbricoides= 4.6%.
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Table 2 displays pre- and post-treatment associations between
plasma levels of antigen-specific IgE and HR; the significance of
any change in association is also displayed. A borderline signifi-
cant association between AHW-IgE and AHW-HR was ob-
served pretreatment (P = .06), which strengthened and became
significant post-treatment (P = .01); however, this change in
strength of association was not significant.
Changes in S. mansoni-HR 8 Weeks Post-Anthelmintic
Treatment
Plasma levels of SWA-IgE and -IgG4 increased significantly
post-treatment (P = .03 and < .001, respectively), SEA-IgE re-
mained unchanged by treatment (P = .07), and SEA-IgG4 de-
creased significantly post-treatment (P = .001, Figure 1). In
line with increased SWA-IgE levels, a significant post-treatment
increase in SWA-HR was observed (Figure 2). SEA-HR in-
creased marginally, but nonsignificantly, post-treatment
(Figure 2).
Pretreatment, no associations were observed between SWA-
or SEA-HR and plasma IgE to the respective antigen (Table 2).
Post-treatment, these associations strengthened, becoming sig-
nificant for both antigens. For SWA, this change in strength of
association was significant (Table 2).
Changes in House Dust Mite-HR 8 Weeks Post-Anthelmintic
Treatment
Plasma HDM-IgG4 and -IgE levels were not significantly affect-
ed by treatment (Figure 1, P > .13). A small but significant
Figure 1. Geometric mean levels of total-IgE, and IgE and IgG4 to AHW,
SWA, SEA, and HDM pretreatment (gray bars) and post-treatment (black
bars). An integer, k, was added to antibody readings before calculating
geometric means to remove zero values; values for k were as follows:
total-IgE = 3.203, AHW-IgE = 0.38, AHW-IgG4 = 0.012, SWA-IgE = 79.2,
SWA-IgG4 = 0.506, SEA-IgE = 9.472, SEA-IgG4 = 0.108, HDM-IgE = 0.228,
HDM-IgG4 = 1.22. IgE levels are expressed in ng/mL and IgG4 levels are
expressed in µg/mL. P-values indicate level of significance for differences
between pre- and post-treatment levels. Abbreviations: AHW, adult hook-
worm antigen extract; HDM, house dust mite allergen; IgE, immunoglobu-
lin E; SEA, soluble egg antigen; SWA, soluble worm antigen.
Figure 2. Pretreatment (gray bars) and post-treatment (black bars) in
vitro basophil histamine release following culture of unwashed, whole
blood with α-IgE or specific antigen. An integer, k, was added to histamine
readings before calculating geometric means to remove zero values; values
for k were as follows: anti-IgE = 0.064, AHW = 1.775, SWA = 0.535,
SEA = 0.920, HDM = 0.096. P-values indicate level of significance for dif-
ferences between pre- and post-treatment release. Abbreviations: AHW,
adult hookworm antigen extract; HDM, house dust mite allergen; IgE, im-
munoglobulin E; SEA, soluble egg antigen; SWA, soluble worm antigen.
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decrease in HDM-HR was observed post-treatment [GM = 0.79
(95% CI, .61, 1.01) pretreatment vs GM = 0.54 (95% CI, .43, .68)
post-treatment, Figure 2]. No overall association was observed
between HDM-HR and HDM-IgE, either pre- or post-
treatment (Table 2).
Effect of Helminth Infection on House Dust Mite-HR
To investigate whether hookworm and/or S. mansoni infection
modifies the immune response to environmental allergens such
as HDM, we included pretreatment prevalence (hookworm) or
intensity (S. mansoni) of infection as effect modifiers in regres-
sion analysis. Although there was no overall association between
pretreatment HDM-IgE and HDM-HR (Table 2), there was ev-
idence that hookworm infection significantly modified the in-
fluence of HDM-IgE on HDM-HR (HW infection–HDM-IgE
interaction significant: LRχ2 = 4.78, P = .03). No association
was observed between HDM-IgE and HDM-HR among hook-
worm-infected children [GM ratioadj = 0.92 (95% CI, .61, 1.40)],
but a strong significant association was observed among chil-
dren without pretreatment infection [GM ratioadj = 2.64 (95%
CI, 1.10, 6.30)] (Figure 3). No significant interaction was ob-
served between S. mansoni infection and HDM-IgE levels on
HDM-HR (LRχ2 = 1.32, P = .25).
Changes in HDM-HR pre- and post-treatment also appeared
to be influenced by pretreatment hookworm infection but also
dependent on post-treatment HDM-IgE levels [pretreatment
hookworm infection–post-treatment HDM-IgE interaction
significant: LRχ2 = 4.69, P = .03]. Among children with pretreat-
ment hookworm infection, HDM-HR increased post-treatment
in a HDM-IgE dependent manner, with greater increases ob-
served among children with higher post-treatment HDM-IgE
levels (Table 3). There was no evidence for pretreatment S. man-
soni infection intensity having a similar effect [pretreatment
S. mansoni infection intensity– post-treatment HDM-IgE inter-
action nonsignificant: LRχ2 = 0.29, P = .59].
Associations Between Helminth Infection and Markers for
Allergy
To investigate whether pretreatment prevalence of hookworm
or intensity of S. mansoni infection had any influence on symp-
toms of allergy, we measured pretreatment SPT sensitivity to
HDM and documented current wheeze. Despite 27% of chil-
dren having HDM-IgE, only 4.2% of children presented with
HDM-SPT sensitivity (Table 1). Although higher levels of
HDM-IgE were associated with a greater risk of HDM-SPT
[ORadj = 1.97 (95% CI, .94, 4.12)], this relationship was
Figure 3. Predicted association between circulating HDM-IgE levels and
house dust mite-induced histamine release among children with hookworm
infection (dashed line) and children without hookworm infection (solid
line). The effect modifying behaviour of pretreatment hookworm infection
on the association between HDM-IgE and HDM-induced histamine release
was analysed using linear regression analysis, adjusting for age, sex, and
SES. A significant hookworm infection–HDM-IgE interaction was observed
(χ2(1) = 4.90, P = .03). Model predicted GM ratios were as follows: hook-
worm infection 0.22 (95% CI, .06, .79); HDM-IgE 2.65 (95% CI, 1.11,
6.33); hookworm*HDM-IgE 0.35 (95% CI, .13, .91); age 9–10 years, 1.33
(95% CI, .66, 2.69); age 11–12 years, 0.86 (95% CI, .44, 1.68); age 13–
16 years, 0.53 (95% CI, .23, 1.21); male sex, 1.50 (95% CI, .89, 2.51); ln
(SES score), 0.72 (95% CI, .40, 1.29). Abbreviations: CI. confidence interval;
GM, geometric mean; HDM, house dust mite allergen; IgE, immunoglobulin
E; SES, socioeconomic status.
Table 2. Pretreatment and Post-treatment Associations Between
Plasma Levels of Antigen-specific IgE and Histamine Release to
the Respective Antigen
Antigen
Adjusteda GM Ratio (95% CI)
Pretreatmentb Post-treatmentc P Valued
t-IgE /anti-IgE 0.75 (.57, 1.00)* 0.91 (.75, 1.10) .21
AHW 1.05 (1.00, 1.11) 1.06 (1.02, 1.11)** .77
SWA 1.18 (.92, 1.50) 1.65 (1.30, 2.10)*** .04
SEA 1.03 (.92, 1.16) 1.16 (1.05, 1.29)** .07
HDM 1.10 (.76, 1.61)e 1.15 (.82, 1.60) .89
Abbreviations: CI, confidence interval; GM, geometric mean; HDM,house dust
mite allergen; IgE, immunoglobulin E; SES, socioeconomic status.
a Age, sex, and SES adjusted.
b GM increase in pre-treatment anti-IgE-induced or antigen-induced histamine
release with each unit increase in pre-treatment plasma levels of t-IgE or IgE to
the same antigen. *<.05.
c GM increase in post-treatment anti-IgE-induced or antigen-induced histamine
releasewith each unit increase in post-treatment plasma levels of t-IgE or IgE to
the same antigen. **<.01, ***<.001.
d Significance of any change in association between non-specific or antigen-
specific-HR and plasma IgE levels pre- vs post-treatment; determined by
2-level linear regression to allow for correlation within children, with time
(pre- or post-treatment) as “level 1” units and child as “level 2” units, and an
interaction term fitted between time and antigen-specific-IgE.
e Significant interaction between HDM-IgE and hookworm infection
(χ2(1) = 4.90, P = .03). Model predicted GM ratios: hookworm infection 0.22
(95% CI, .06, .79); HDM-IgE 2.65 (95% CI, 1.11, 6.33); hookworm*HDM-IgE
0.35 (95% CI, .13, .91).
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nonsignificant (P = .09). HDM-HR was significantly associated
with HDM-SPT sensitivity [ORadj = 1.87 (95% CI, 1.06, 3.29),
P = .01]. There was no evidence for either hookworm or S. man-
soni infection modifying either of these associations (interaction
term P > .09) or for infection influencing risk of HDM-SPT
sensitivity (P > .13); however, IgG4 responsiveness to AHW
was associated with a reduced risk of HDM-SPT sensitivity
(ORadj = 0.21, P = .03).
Similarly to SPT sensitivity, prevalence of wheeze in the last
12 months was also low, with only 8.22% of children affected.
No association was observed between HDM-IgE or HDM-
SPT sensitivity and risk of wheeze [ORadj = 1.18 (95% CI, .58,
2.39), P = .65 and ORadj = 1.37 (0.16, 12.04), P = .78, respective-
ly], a borderline significant association was observed between
HDM-HR and risk of wheeze [ORadj = 1.35 (95% CI, .96,
1.91), P = .07]. Again, there was no evidence for either hook-
worm or S. mansoni infection influencing these relationships
(interaction terms P > .14); however, hookworm infection and
IgG4 responsiveness to AHW were both associated with a sig-
nificantly decreased risk of wheeze [ORadj = 0.29 (95% CI, .10,
.87), P = .03 and ORadj = 0.36 (95% CI, .13, 1.02), P = .05, re-
spectively]. The protective influence of hookworm infection
against wheeze appeared dose-dependent, with heavier hook-
worm infection intensities associated with lowest risk of wheeze
[ORadj = 0.80 (95% CI, .65, .98), P = .03]. There was no associ-
ation between S. mansoni infection intensity and risk of wheeze
[ORadj = 1.05 (95% CI, .82, 1.34)].
DISCUSSION
There is growing evidence that infection with some helminth
species offers protection against allergy [13, 14]. Poor correla-
tions between as-IgE and SPT sensitivity and as-IgE and clinical
signs of allergy in helminth-infected populations [10–12] sug-
gest that this protection may act by uncoupling asIgE from its
effector mechanisms. We investigated this hypothesis in Ugan-
dan schoolchildren resident in a S. mansoni and hookworm
coendemic area, using whole blood assays to include both cel-
lular and humoral factors. We observed increased nonspecific
and helminth-specific HR after anthelmintic treatment, as
well as stronger associations between helminth-specific IgE
and helminth-specific HR. There was also evidence for hook-
worm infection modifying the influence of HDM-IgE on
HDM-HR, and reducing risk of wheeze. Further, AHW-IgG4
responsiveness was associated with reduced risk of HDM-SPT
sensitivity. Although average age and hookworm and S. manso-
ni infection prevalence were slightly higher among children
completing the study, this is unlikely to have biased results;
all other measured characteristics were comparable among
those completing and not completing the study.
Few studies have investigated basophil function during
human helminth infection. Although basophil competence
has been demonstrated in human hookworm infection [32],
ours is the first study to our knowledge to investigate treatment
effects on basophil function in a hookworm-endemic popula-
tion. Basophil function in S. mansoni infection has shown sim-
ilar trends toward increased HR post-treatment. For example,
adult S. mansoni-antigen-induced HR from basophils passively
sensitized with human infection sera increased post-treatment
and suggested that IgG4-mediated down-regulation occurred
during active infection [28]. We also observed increases in
α-IgE-, SEA-, and SWA-HR in washed basophils from Ugandan
fishermen exposed to S. mansoni [27], whereas Larson et al [33]
reported increases in nonspecific IgE-dependent and IgE-
independent HR in washed basophils following anthelmintic
treatment of a small sample of Ascaris lumbricoides- and
Trichuris trichiura-infected children.
We have previously observed elevated blood basophil counts
in helminth-infected individuals using precise basophil mea-
surements (Cahen, unpublished data), indicating that the
post-treatment increases in measured HR to anti-IgE, SWA-
HR, and AHW-HR observed here, truly reflect enhanced HR
rather than simply increased circulating basophil numbers. Be-
cause we used whole blood assays to measure HR, this increase
in HR could reflect changes in both cellular responsiveness (ie,
intracellular signal transduction) and humoral factors (ie, circu-
lating total and specific IgE and specific IgG4).
Schistosomiasis treatment with praziquantel disrupts the
tegument of adult worms, exposing otherwise sequestered aller-
gen-like antigens such as Schistosoma mansoni tegumental-
allergen-like 1 protein (SmTAL1). Hence, anti-worm-IgE levels
often increase post-treatment [24, 34], as here. Increases in
SWA-IgE could explain observed increases in SWA-HR; howev-
er it is unlikely to explain the significant increased strength of
association between SWA-IgE and SWA-HR. In addition,
Table 3. Factors Associated With Post-treatment Changesa in
HDM-induced Histamine Release
GM ratiob (CI95%) P Value
HW infected at baseline 9.19 (1.59, 53.22) .01
Post-Rx HDM-IgE 0.34 (.10, 1.14) .07
HW infection*Post-Rx HDM-IgE 4.19 (1.11, 15.81) .03
SES 1.22 (.54, 2.76) .61
9–10 y 0.64 (.24, 1.67)
11–12 y 1.06 (.42, 2.67)
13–16 y 1.01 (.30, 3.37) .68
Male 0.86 (.42, 1.76) .66
Abbreviations: CI, confidence interval; GM, geometric mean; HDM,house dust
mite allergen; IgE, immunoglobulin E; SES, socioeconomic status.
a Calculated as ln(post-Rx histamine release)–ln(pre-Rx histamine release).
b Estimated using multiple regression analysis.
c Determined by likelihood ratio tests.
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responses to schistosome egg and adult hookworm antigens are
generally not boosted by treatment [24, 34, 35]. In this study,
neither SEA-IgE nor AHW-IgE was significantly affected by
treatment. However, SEA-IgG4 and AHW-IgG4 levels fell
post-treatment, most markedly for AHW-IgG4. This drop in
IgG4 levels, together with increases in α-IgE-HR, the dramatic
increases in AHW-HR, and the increased strength of associa-
tion between helminth-specific IgE and helminth-specific HR
post-treatment, suggests a state of immunosuppresion during
chronic helminth infection, which reduces basophils’ ability
to respond to IgE-mediated activation. The fact that associations
between IgE and IgE-mediated HR appear restored 8 weeks
post-treatment, demonstrates that this helminth-mediated sup-
pression is rapidly reversed upon anthelmintic treatment.
Unfortunately, because schistosomiasis and hookworm were
treated concurrently, it is not possible to determine whether one
or both parasites are responsible for this suppression. However,
hookworm is clearly implicated because hookworm infection
significantly modified the association between HDM-IgE and
HDM-HR. No association was observed between HDM-IgE
and HDM-HR among hookworm-infected children, but a
strong positive association was observed among uninfected chil-
dren. Further, HDM-HR boosted positively after treatment with
increasing post-treatment HDM-IgE levels in children with pre-
treatment hookworm infection, but no post-treatment HDM-
HR boosting was observed among uninfected children.
There is also evidence that this hookworm-mediated sup-
pression of basophil responsiveness to HDM has systemic ef-
fects. Prevalence of wheeze and HDM-SPT sensitivity was
low: only 8% and 4% of children affected, respectively, despite
27% having detectable HDM-IgE responses. This is comparable
to other wheeze prevalence estimates in Africa [8, 36], but
contrasts with regional estimates in Western Europe, North
America, and Oceania of 16.7%–24.2% and 8.1%–24.6%
among 13–14 and 6–7 year-olds, respectively [37]. In addition,
similarly to other studies [13, 38], hookworm infection was neg-
atively associated with current wheeze, and AHW-IgG4 nega-
tively associated with both current wheeze and HDM-SPT
sensitivity.
These negative associations with AHW-IgG4, the marked
post-treatment decrease in AHW-IgG4 and simultaneous in-
crease in HR, suggest basophil suppression may be in part
IgG4-mediated. In allergen-specific immunotherapy, increases
in asIgG4 are more consistently associated with clinical effec-
tiveness than changes in IgE [39], and IgG4-containing sera
from treated patients has been shown to block basophil activa-
tion [40, 41]. Because we used an unwashed system to measure
HR, IgG4-mediated suppression could either be through IgG4
competing with IgE for the same epitopes, and/or through
co-engagement of low-affinity IgG receptors FcγRII, found on
basophils, with the high-affinity receptor FcεRI. FcγRII/FcεRI
co-stimulation on human basophils has been shown to result
in FcγRIIB-dependent inhibition of IgE-induced activation
[22, 42]; both with FcγRII and FcεRI co-crosslinking the same
antigen and with costimulation with separate antigens [43]. The
increase in nonspecific (α-IgE-mediated) HR post-treatment
could additionally suggest that helminth infection may also reg-
ulate basophil cell function nonspecifically, independently of
specific IgG4; conversely, however, observed increases in
α-IgE-HR could also be related to in vitro total-IgE mediated
interference.
In conclusion, our results suggest that basophil responsive-
ness to IgE-mediated activation is suppressed in S. mansoni
and hookworm coinfection but is rapidly restored by anthel-
mintic treatment. Hookworm-mediated suppression may addi-
tionally suppress HDM-IgE-induced HDM-HR and, in turn,
allergy. We speculate that this basophil suppression may be in
part IgG4-mediated. Further studies into underlying mecha-
nisms are needed to determine if this is the case and its clinical
relevance to allergy management.
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